Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 35% ± 11% | |
lung | 15 studies | 32% ± 16% | |
intestine | 9 studies | 28% ± 12% | |
kidney | 7 studies | 26% ± 6% | |
lymph node | 5 studies | 29% ± 11% | |
liver | 5 studies | 26% ± 13% | |
uterus | 4 studies | 34% ± 17% | |
breast | 4 studies | 22% ± 5% | |
brain | 4 studies | 19% ± 3% | |
placenta | 3 studies | 23% ± 2% | |
bone marrow | 3 studies | 31% ± 9% | |
skin | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2954.87 | 258 / 258 | 100% | 48.54 | 230 / 230 |
ovary | 100% | 2120.24 | 180 / 180 | 100% | 120.79 | 430 / 430 |
pancreas | 100% | 1797.12 | 328 / 328 | 100% | 59.79 | 178 / 178 |
thymus | 100% | 2393.92 | 653 / 653 | 100% | 71.77 | 605 / 605 |
uterus | 100% | 1671.50 | 170 / 170 | 100% | 68.68 | 459 / 459 |
esophagus | 100% | 2138.59 | 1444 / 1445 | 100% | 46.92 | 183 / 183 |
liver | 100% | 1486.21 | 226 / 226 | 100% | 49.58 | 405 / 406 |
stomach | 100% | 1553.18 | 359 / 359 | 100% | 57.59 | 285 / 286 |
kidney | 100% | 2139.12 | 89 / 89 | 100% | 55.77 | 897 / 901 |
intestine | 100% | 1748.14 | 966 / 966 | 99% | 69.74 | 524 / 527 |
brain | 99% | 1015.57 | 2624 / 2642 | 100% | 56.39 | 705 / 705 |
skin | 100% | 2763.09 | 1804 / 1809 | 100% | 61.60 | 470 / 472 |
prostate | 100% | 2327.45 | 245 / 245 | 99% | 82.72 | 498 / 502 |
breast | 100% | 2324.19 | 459 / 459 | 99% | 63.39 | 1108 / 1118 |
bladder | 100% | 1860.76 | 21 / 21 | 99% | 76.23 | 499 / 504 |
lung | 100% | 1882.68 | 576 / 578 | 99% | 50.66 | 1145 / 1155 |
adipose | 100% | 2390.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 121.38 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 116.32 | 29 / 29 |
spleen | 100% | 2851.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 82.65 | 1 / 1 |
blood vessel | 100% | 1558.92 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3150.64 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 748.28 | 813 / 861 | 0% | 0 | 0 / 0 |
muscle | 54% | 291.33 | 434 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0009051 | Biological process | pentose-phosphate shunt, oxidative branch |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0017057 | Molecular function | 6-phosphogluconolactonase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PGLS |
Protein name | 6-phosphogluconolactonase 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31) |
Synonyms | HEL-S-304 hCG_1778174 |
Description | FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. . FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. . FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. . FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. . |
Accessions | ENST00000594761.5 M0R1L2 ENST00000595782.1 ENST00000252603.7 A0A0K0K1K7 ENST00000600923.5 M0R0U3 O95336 M0R261 |